A genomic library ofActinomyces viscosus T14V DNA in Agtll was screened for expression of neuraminidase activities. Four recombinant clones were detected that gave blue fluorescence upon incubation with a fluorogenic substrate, 2'-(4-methylumbelliferyl)-a-D-N-acetylneuraminic acid. Of these, two were identical, and all of the neuraminidase-positive clones shared a common 3.4-kbp DNA region. Expression of the enzyme activities in Escherichia coli carrying the cloned DNA was independent of the lacZ promoter of the vector. Maxicell analysis revealed that the 3.4-kbp DNA insert directed synthesis of a protein with an apparent molecular mass of 100,000 Da. The protein from cell extracts of E. coli clones migrated as a single band that stained for enzyme activity after electrophoresis in a nondissociating polyacrylamide gel. Moreover, human erythrocytes incubated previously with cell lysates from neuraminidase-positive E. coli were hemagglutinated by Actinomyces spp. The enzyme expressed by E. coli was active on substrates containing o-2,3 and a-2,6 ketosidic linked sialyl residues. Similar substrate specificities were obtained for both the extracellular and cell-associated neuraminidases from A. viscosus T14V. The 3.4-kbp insert hybridized to DNA fragments in a Southern blot containing A. viscosus T14V chromosomal DNA that had been digested with various restriction endonucleases. Data from hybridization studies show that A. viscosus T14V contains a single copy of the neuraminidase gene.
The adherence of oral Actinomyces spp. to host tissues and other bacteria involves distinct fimbrial types present on the cell surface of these organisms (8) . Fimbriae designated type 1 are implicated in attachment to the tooth surface (11) , while those designated type 2 are associated with lectinlike interactions with mammalian cells (6, 34) and other bacteria (8) . The latter interactions are reversible in the presence of lactose. The fimbria-mediated adherence of these organisms to eucaryotic cells, including buccal epithelial cells (6, 8) , human erythrocytes (9, 15, 17) , and polymorphonuclear leukocytes (34) , is initiated by treatment of the mammalian cell types with neuraminidase. Exposure of the sialoglycoproteins to neuraminidase results in an unmasking of the galactose or galactosamine moieties that serve as receptors for the type 2 fimbriae of these organisms (5, 9) . Since neuraminidase has been detected in saliva and plaque fluids (28, 30) , it is likely that interactions between neuraminidase and salivary glycoproteins occur in vivo, thereby modulating bacterial adherence.
Results of previous studies showed that neuraminidase is produced by several indigenous plaque bacteria. These include strains of Actinomyces (15, 17, 25) , Streptococcus (3), Haemophilus (37) , and Bacteroides (19) species. However, the influence of enzyme production from each of the various bacteria on the oral ecology has not been investigated. For instance, it is not known whether the levels of enzyme synthesis by each of the different organisms are comparable or whether there is a selection for strains that produce higher levels of enzyme activity in localized areas within the oral environment. A recent study by Moncla and Braham (25) reported detection of neuraminidase from 79% of 71 Actinomyces spp. The results complemented a previous study by Costello et al. (15) , who demonstrated neuraminidase activities in a large number of Actinomyces spp. ( approximately 80% of all strains tested). Moreover, Cos-* Corresponding author.
tello (14a) indicated that about 10% of the total neuraminidase activity from Actinomyces viscosus T14V was found in the culture supernatant fluid, while >80% of the enzyme activity was cell associated. Interestingly, the soluble neuraminidase initiated hemagglutination by Actinomyces spp., while the cell-associated form of the enzyme did not (15) . It is not known whether differences in substrate specificity between the two forms of the enzyme may have contributed to the different activities on human erythrocytes. A neuraminidase was isolated recently from A. viscosus DSM 43798 (36) . Results from that study showed that the extracellular and cell-associated neuraminidase from this strain shared identical properties. However, hemagglutination of erythrocytes by this strain, as influenced by the two forms of the enzyme, was not presented.
This study focuses on the molecular cloning of a neuraminidase gene from A. viscosus T14V in Escherichia coli. The enzyme activity was detected with a fluorogenic substrate (29) , using a rapid screening method similar to that described by Russo et al. (32) . Isolation of the neuraminidase gene provides the basis for characterization of the gene and biosynthesis of the enzyme in Actinomyces spp. at the molecular level.
MATERIALS AND METHODS Bacteria and plasmids. Table 1 summarizes the bacteria, plasmids, and bacteriophage used in this study. E. coli strains were grown in Luria broth (L-broth; 24) supplemented with antibiotics or nutrients as required for the particular strains. Actinomyces spp. were grown in cariesactive medium supplemented with 0.2% glucose (15) .
Construction and screening of A. viscosus T14V genomic library in E. coli. A. viscosus T14V chromosomal DNA was prepared as described previously (40) . The genomic DNA was partially digested with SmaI (Bethesda Research Laboratories Inc., Gaithersburg, Md.) and fractionated through a 10 to 40% sucrose gradient as described in reference 24. (25) . Aliquots of the samples also were analyzed in 7.5% nondissociating polyacrylamide gels. After electrophoresis, the gels were soaked;in 0.17 M sodium acetate, pH 5.4, for 15 min and stained with MUNeuNAc in the same buffer at 37°C for 30 min.
Maxicell protein analysis. E. coli CSR603 carrying different plasmids (Table 1) was seeded in 10 ml of minimal growth medium (M9 minimal salt solution [24] supplemented with 1% Casamino Acids [Difco Laboratories, Detroit, Mich.] and 0.1 xg of thiamine per ml). At an A660 of 0.5, the culture was exposed to UV irradiation at 2.5 J in a Stratalinker (model 1800; Stratagene Cloning Systems). This condition was equivalent to the UV irradiation used by Sancar et al. (33) . The irradiated culture was incubated in the presence of 100 ,ug of D-cycloserine (Sigma Chemical Co.) per ml for 12 h. The bacteria were incubated for 1 h at 37°C in 5 ml of sulfate-free minimal growth medium and in 35S-methionine (Du Pont New England Nuclear, Boston, Mass.) at 5 ,uCi/ml for an additional hour. The labeled cells were lysed in 200 [L of SDS-containing sample buffer (23) . The lysates were boiled at 100°C for 5 min and analyzed on 10% SDSpolyacrylamide gels. The gels were fixed, dried, and exposed to Kodak XAR-5 film (Eastman Kodak Co., Rochester,
N.Y.).
Southern hybridization and DNA probe. A. viscosus T14V genomic DNA (2 ,ug) was digested to completion with several restriction endonucleases. The digested DNA fragments were separated by agarose gel electrophoresis and transferred to GeneScreen (New England Nuclear Corp.) under conditions recommended by the manufacturer. Membranes were prehybridized at 42°C for 2 to 4 h in a solution containing 5x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) (24) , 50% formamide, 10% dextran sulfate, lx Denhardt's solution, 1% SDS, 1 M NaCl, 0.5% sodium pyrophosphate, and 200 [Lg of denatured herring sperm DNA (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) per ml. Denatured radiolabeled DNA probe was added, and hybridization was continued for 18 to 20 h at the same temperature. Membranes were washed with 0.1 x SSC containing 0.5% SDS at 65°C for 1 h with one change of buffer. The filters were air dried and exposed to Kodak XAR-5 film.
DNA was labeled with o-355-dCTP (1, Other substrates used in the present study included: bovine submaxillary mucin (BSM), N-acetylneuramin-lactose (human or bovine), colominic acid (all chemicals obtained from Sigma Chemical Co.), and de-O-acetylated BSM prepared by incubating BSM in 0.05 M sodium carbonate as described previously (20) . To quantitate cell-associated neuraminidase, 150 pl of a washed cell suspension was used in the reaction mixture. Bacteria were removed after the incubation period by centrifugation, and the supernatant fluid was assayed for sialic acid contents.
RESULTS
Isolation of Agtll clones that expressed neuraminidase activities. A fluorogenic neuraminidase substrate, MUNeu NAc, was used to screen the genomic library of A. viscosus T14V DNA in Xgtll for expression of enzyme activities. Less than 5% of the library consisted of nonrecombinant plaques, as determined by plating of the phages on a medium containing 5-bromo-4-chloro-3-indolyl-3-galactoside and IPTG. Of approximately 3 x 105 plaques examined, four positive clones were detected by their ability to convert the fluorogenic substrate to give a blue fluorescence under UV light. Figure 1 shows the sensitivity of the filter paper spot assay for monitoring enzyme production in neuraminidasepositive strains. Each spot in row A of Fig. 1 Table   shown ). Thus, all of the neuraminidase-positive clones exno effect on pressed the same neuraminidase activity. Since a higher ), and A1720 level of neuraminidase activity was obtained from cell lynduced and sates of the X1415 lysogen under IPTG induction (Table 2) , it In contrast, is likely that the lac promoter of the vector directs transcripvated in the tion of the neuraminidase gene present in this clone. Further, hese results transcription of the cloned gene probably initiates near the of the DNA rightmost EcoRI site on the physical map of X1415 (Fig. 2 ). strains were The 3.4-and 4.2-kbp EcoRI DNA fragments from X1415 and X127, respectively, were cloned separately into the is of restricEcoRI site of pBluescript SK+. Two pairs of clones were )ntained the obtained: one pair contained the 3.4-kbp insert and the other n the same contained the 4.2-kbp DNA insert in both orientations with fXgtll ( Fig. respect to the lacZ promoter of the vector (Table 1) . Neuras similar to aminidase activities were detected from E. coli carrying loned in the these plasmids, as monitored by the qualitative filter spot DNA insert assay (Fig. 1, row B) . Characterization of neuraminidase-positive E. coli strains. E. coli harboring the recombinant plasmids listed in Table 1 were stable and expressed measurable levels of neuraminin NC dase. Table 3 shows that E. coli carrying pMY1415-5 or spectively, synthesized and secreted neuraminidase at comparable levels. As expected, similar levels of expression were observed in E. coli carrying pMY1415-6 and pMY450-5, in which the inserts were in the reverse orientations (see calculated confidence intervals in Table 3 ). In a M127 separate experiment, subcellular fractionation of E. coli carrying pMY1415-5 revealed that >80% of the total enzyme produced was associated with the cytoplasmic and mem-M1210 brane fractions, while 3.4% of the activity was retained in X1720 the periplasmic fraction. Extracellular neuraminidase accounted for 10% of the total activity (data not shown).
As shown in Fig. 3 genic substrate (Fig. 3, lanes 2 and 3) . The enzyme from E. icantly slower than the Clostridium perfringens neuraminidase (Rf = 0.39; Fig. 3, lane 6 ).
The proteins encoded by pMY1415-5 and pMY450-1 in the E. coli maxicell strain CSR603 were labeled with 35S-methionine. Both plasmids directed the synthesis of a protein with an apparent molecular mass of 100,000 Da (Fig. 4, lanes 4  and 5) , which was absent in maxicell proteins from E. coli carrying pSK+ (Fig. 4, lane 3) .
Neuraminidase-initiated hemagglutination and substrate specificities. The rate at which sialic acid was released from packed human erythrocytes by neuraminidase in 50 ,ug of the E. coli MV1184(pMY1415-5) soluble cell lysate was similar to that released by 15 ,ig of commercially purified C. perfringens neuraminidase (P = 0.2647) ( Substrate specificities of neuraminidase isolated from E. coli clones were similar to the specificities of the enzyme isolated from A. viscosus T14V ( Table 5 ). The enzyme was active on substrates containing (x-2,3-and a-2,6-linked sialic acid. At least twice as much sialic acid was released from (36) , who demonstrated identical substrate specificity between the two forms of the enzyme from A. viscosus DSM 43798. The A. viscosus T14V neuraminidase hydrolyzes sialic acid residues that are either a-2,3 or ot-2,6 linked to galactose, N-acetylgalactosamine, or lactose. When N-acetylneuramin-lactose from bovine colostrum (containing 15% a-2,3 and 85% a-2,6 neuraminyl-lactose isomers) and from human milk (containing 85% a-2,6 and 15% oa-2,3 neuraminyl-lactose isomers) were used as substrates, the results (Table 4) suggested that the 6'-neuraminyl-lactose isomer was more susceptible to this enzyme. Further studies with glycoproteins with unique ketosidic linkages will be required to determine the specific substrate preferences of this enzyme. The reduced rate of hydrolysis by the A. viscosus T14V neuraminidase on BSM was attributed to the presence of 0-acetylated sialic acid residues in this substrate. This conclusion was based on the observation that increased levels of sialic acid were released from alkali-treated BSM versus untreated BSM (Table 4 ). The resistance of 0-acetylated or N-substituted sialic acids to hydrolysis by other bacterial neuraminidases such as those from C. perfringens or Vibrio cholerae (14, 26) and from A. viscosus DSM 43798 (36) has been described before. Thus, with respect to hydrolytic properties, the A. viscosus T14V neuraminidase shares certain similarities with neuraminidases from A. viscosus DSM 43798 (36), C. perfringens (7), and other bacteria (18, 22, 38) that have broader ranges of substrate specificity. It is of interest that the properties of neuraminidase from A. viscosus T14V are not identical to those of A. viscosus DSM 43798. For instance, while neuraminidase from the latter strain hydrolyzes a-2,3 linkages at rates faster than a-2,6 ketosidic bonds and is apparently quite active on colominic acid containing ox-2,8-linked sialic acid residues (36), the A. viscosus T14V neuraminidase does not exhibit similar characteristics (Table 5) .
Neuraminidase has been isolated from a variety of microorganisms (13, 31) and is often considered a potential virulence factor contributing to the pathogenesis of the organisms. Most neuraminidase-producing organisms secrete large amounts of the enzyme into the growth medium (31) . Exceptions to this general observation include Klebsiella aerogenes (27) , Pasteurella multocida (16), Bacteroides spp. (19) , and Actinomyces spp. (15, 17, 36) , which possess predominately cell-associated neuraminidase. At present, it is not known whether the cell-bound neuraminidase of Actinomyces spp. is associated with the bacterial cell wall alone or is also anchored in the cytoplasmic membrane.
Results from previous studies suggested that some of the cell-bound enzyme must be associated with the cell wall. This is based on the observations that the cell-associated enzyme was released when treated with lysozyme (14a, 36) and that, upon storage, a small fraction of the cell-associated enzyme was released from the cell suspension of Actinomyces spp. (15; unpublished data). It will be of interest to determine the factors that influence enzyme release from the bacteria, since only the soluble cell-free neuraminidase was capable of initiating bacterium-mediated hemagglutination (15) . Further studies will be necessary to elucidate the relationship between the cell-free and cell-associated neuraminidases from A. viscosus T14V. Clearly, isolation of the nanH gene in the present study, and the finding that E. coli clones secreted the enzyme into the growth medium, should facilitate future studies focusing on the biochemical analysis of the enzyme from this organism. Data from these studies should provide insights into the biosynthesis of neuraminidase by Actinomyces spp.
